Serveur d'exploration Stress et Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Association of chronic fatigue syndrome with premature telomere attrition.

Identifieur interne : 000917 ( Ncbi/Merge ); précédent : 000916; suivant : 000918

Association of chronic fatigue syndrome with premature telomere attrition.

Auteurs : Mangalathu S. Rajeevan [États-Unis] ; Janna Murray [États-Unis] ; Lisa Oakley [États-Unis] ; Jin-Mann S. Lin [États-Unis] ; Elizabeth R. Unger [États-Unis]

Source :

RBID : pubmed:29486769

Descripteurs français

English descriptors

Abstract

Chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), is a severely debilitating condition of unknown etiology. The symptoms and risk factors of ME/CFS share features of accelerated aging implicated in several diseases. Using telomere length as a marker, this study was performed to test the hypothesis that ME/CFS is associated with accelerated aging.

DOI: 10.1186/s12967-018-1414-x
PubMed: 29486769

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:29486769

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Association of chronic fatigue syndrome with premature telomere attrition.</title>
<author>
<name sortKey="Rajeevan, Mangalathu S" sort="Rajeevan, Mangalathu S" uniqKey="Rajeevan M" first="Mangalathu S" last="Rajeevan">Mangalathu S. Rajeevan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329, USA. mor4@cdc.gov.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329</wicri:regionArea>
<wicri:noRegion>30329</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Murray, Janna" sort="Murray, Janna" uniqKey="Murray J" first="Janna" last="Murray">Janna Murray</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329</wicri:regionArea>
<wicri:noRegion>30329</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Oakley, Lisa" sort="Oakley, Lisa" uniqKey="Oakley L" first="Lisa" last="Oakley">Lisa Oakley</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329</wicri:regionArea>
<wicri:noRegion>30329</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lin, Jin Mann S" sort="Lin, Jin Mann S" uniqKey="Lin J" first="Jin-Mann S" last="Lin">Jin-Mann S. Lin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329</wicri:regionArea>
<wicri:noRegion>30329</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Unger, Elizabeth R" sort="Unger, Elizabeth R" uniqKey="Unger E" first="Elizabeth R" last="Unger">Elizabeth R. Unger</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329</wicri:regionArea>
<wicri:noRegion>30329</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29486769</idno>
<idno type="pmid">29486769</idno>
<idno type="doi">10.1186/s12967-018-1414-x</idno>
<idno type="wicri:Area/PubMed/Corpus">000278</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000278</idno>
<idno type="wicri:Area/PubMed/Curation">000278</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000278</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000290</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000290</idno>
<idno type="wicri:Area/Ncbi/Merge">000917</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Association of chronic fatigue syndrome with premature telomere attrition.</title>
<author>
<name sortKey="Rajeevan, Mangalathu S" sort="Rajeevan, Mangalathu S" uniqKey="Rajeevan M" first="Mangalathu S" last="Rajeevan">Mangalathu S. Rajeevan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329, USA. mor4@cdc.gov.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329</wicri:regionArea>
<wicri:noRegion>30329</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Murray, Janna" sort="Murray, Janna" uniqKey="Murray J" first="Janna" last="Murray">Janna Murray</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329</wicri:regionArea>
<wicri:noRegion>30329</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Oakley, Lisa" sort="Oakley, Lisa" uniqKey="Oakley L" first="Lisa" last="Oakley">Lisa Oakley</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329</wicri:regionArea>
<wicri:noRegion>30329</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lin, Jin Mann S" sort="Lin, Jin Mann S" uniqKey="Lin J" first="Jin-Mann S" last="Lin">Jin-Mann S. Lin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329</wicri:regionArea>
<wicri:noRegion>30329</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Unger, Elizabeth R" sort="Unger, Elizabeth R" uniqKey="Unger E" first="Elizabeth R" last="Unger">Elizabeth R. Unger</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329</wicri:regionArea>
<wicri:noRegion>30329</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of translational medicine</title>
<idno type="eISSN">1479-5876</idno>
<imprint>
<date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Fatigue Syndrome, Chronic (metabolism)</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Telomere (metabolism)</term>
<term>Telomere Homeostasis</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Homéostasie des télomères</term>
<term>Humains</term>
<term>Mâle</term>
<term>Syndrome de fatigue chronique (métabolisme)</term>
<term>Télomère (métabolisme)</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Fatigue Syndrome, Chronic</term>
<term>Telomere</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Syndrome de fatigue chronique</term>
<term>Télomère</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Telomere Homeostasis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Homéostasie des télomères</term>
<term>Humains</term>
<term>Mâle</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), is a severely debilitating condition of unknown etiology. The symptoms and risk factors of ME/CFS share features of accelerated aging implicated in several diseases. Using telomere length as a marker, this study was performed to test the hypothesis that ME/CFS is associated with accelerated aging.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">29486769</PMID>
<DateCompleted>
<Year>2019</Year>
<Month>06</Month>
<Day>12</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>06</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1479-5876</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>16</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2018</Year>
<Month>02</Month>
<Day>27</Day>
</PubDate>
</JournalIssue>
<Title>Journal of translational medicine</Title>
<ISOAbbreviation>J Transl Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Association of chronic fatigue syndrome with premature telomere attrition.</ArticleTitle>
<Pagination>
<MedlinePgn>44</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s12967-018-1414-x</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND">Chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), is a severely debilitating condition of unknown etiology. The symptoms and risk factors of ME/CFS share features of accelerated aging implicated in several diseases. Using telomere length as a marker, this study was performed to test the hypothesis that ME/CFS is associated with accelerated aging.</AbstractText>
<AbstractText Label="METHODS">Participant (n = 639) data came from the follow-up time point of the Georgia CFS surveillance study. Using the 1994 CFS Research Case Definition with questionnaire-based subscale thresholds for fatigue, function, and symptoms, participants were classified into four illness groups: CFS if all criteria were met (n = 64), CFS-X if CFS with exclusionary conditions (n = 77), ISF (insufficient symptoms/fatigue) if only some criteria were met regardless of exclusionary conditions (n = 302), and NF (non-fatigued) if no criteria and no exclusionary conditions (n = 196). Relative telomere length (T/S ratio) was measured using DNA from whole blood and real-time PCR. General linear models were used to estimate the association of illness groups or T/S ratio with demographics, biological measures and covariates with significance set at p < 0.05.</AbstractText>
<AbstractText Label="RESULTS">The mean T/S ratio differed significantly by illness group (p = 0.0017); the T/S ratios in CFS (0.90 ± 0.03) and ISF (0.94 ± 0.02) were each significantly lower than in NF (1.06 ± 0.04). Differences in T/S ratio by illness groups remained significant after adjustment for covariates of age, sex, body mass index, waist-hip ratio, post-exertional malaise and education attainment. Telomere length was shorter by 635, 254 and 424 base pairs in CFS, CFS-X and ISF, respectively, compared to NF. This shorter telomere length translates to roughly 10.1-20.5, 4.0-8.2 and 6.6-13.7 years of additional aging in CFS, CFS-X and ISF compared to NF respectively. Further, stratified analyses based on age and sex demonstrated that the association of ME/CFS with short telomeres is largely moderated by female subjects < 45 years old.</AbstractText>
<AbstractText Label="CONCLUSIONS">This study found a significant association of ME/CFS with premature telomere attrition that is largely moderated by female subjects < 45 years old. Our results indicate that ME/CFS could be included in the list of conditions associated with accelerated aging. Further work is needed to evaluate the functional significance of accelerated aging in ME/CFS.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rajeevan</LastName>
<ForeName>Mangalathu S</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329, USA. mor4@cdc.gov.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Murray</LastName>
<ForeName>Janna</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Influenza Division, Centers for Disease Control and Prevention, Atlanta, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Oakley</LastName>
<ForeName>Lisa</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>College of Public Health and Human Services, Oregon State University, Corvallis, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lin</LastName>
<ForeName>Jin-Mann S</ForeName>
<Initials>JS</Initials>
<AffiliationInfo>
<Affiliation>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Unger</LastName>
<ForeName>Elizabeth R</ForeName>
<Initials>ER</Initials>
<AffiliationInfo>
<Affiliation>Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2018</Year>
<Month>02</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Transl Med</MedlineTA>
<NlmUniqueID>101190741</NlmUniqueID>
<ISSNLinking>1479-5876</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D015673" MajorTopicYN="N">Fatigue Syndrome, Chronic</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016615" MajorTopicYN="N">Telomere</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D059505" MajorTopicYN="N">Telomere Homeostasis</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">Chronic fatigue syndrome</Keyword>
<Keyword MajorTopicYN="Y">Immunosenescence</Keyword>
<Keyword MajorTopicYN="Y">Myalgic encephalomyelitis</Keyword>
<Keyword MajorTopicYN="Y">Stress</Keyword>
<Keyword MajorTopicYN="Y">Telomere attrition</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2017</Year>
<Month>10</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2018</Year>
<Month>02</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2018</Year>
<Month>3</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2018</Year>
<Month>3</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>6</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">29486769</ArticleId>
<ArticleId IdType="doi">10.1186/s12967-018-1414-x</ArticleId>
<ArticleId IdType="pii">10.1186/s12967-018-1414-x</ArticleId>
<ArticleId IdType="pmc">PMC5830066</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Soc Personal Psychol Compass. 2012 Nov 1;6(11):807-825</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23162608</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Menopause. 2015 Aug;22(8):826-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25647777</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Mol Med (Berl). 2002 Nov;80(11):689-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12436345</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Biosci (Landmark Ed). 2017 Jan 1;22:117-127</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27814605</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011;6(5):e19687</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21602933</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 2009 Feb;37(3):e21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19129229</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Biosyst. 2017 Jan 31;13(2):371-379</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28059425</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sleep Med. 2015 May;16(5):559-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25890781</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exerc Rehabil. 2016 Jun 30;12(3):238-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27419121</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuroimmunol. 2017 Feb 15;303:43-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28038892</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mutat Res. 2010 Jan 5;683(1-2):68-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19879280</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Popul Health Metr. 2007 Jun 08;5:5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17559660</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Genet. 2015 Jul;134(7):679-89</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25986438</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lupus. 2007;16(4):265-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17439933</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2004 Feb 14;363(9408):507-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14975611</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Psychosom Res. 1995 Apr;39(3):315-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7636775</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes (Basel). 2016 Sep 03;7(9):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27598205</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Health Promot Chronic Dis Prev Can. 2015 Mar;35(1):3-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25811400</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JCI Insight. 2016 Dec 22;1(21):e89376</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28018972</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Aging (Albany NY). 2017 Mar 8;9(3):955-963</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28273655</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Med Care. 1992 Jun;30(6):473-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1593914</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 2014 Dec;99(12):4607-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25188715</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2011 Oct;25(7):1292-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21536122</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Discov. 2017 Feb;7(2):165-176</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27979832</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17312-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15574496</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cardiovasc Pharmacol Ther. 2004 Sep;9(3):203-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15378141</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann N Y Acad Sci. 2015 Sep;1351:11-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25943573</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychoneuroendocrinology. 2016 May;67:153-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26897704</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Med. 2014 Oct 01;12:167</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25274261</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neuropharmacol. 2015;13(5):701-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26411464</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEBS J. 2013 Jul;280(14):3180-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23647631</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Med. 2009 Oct 12;7:57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19818157</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Genet. 2012;8(5):e1002696</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22661914</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):E5472-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27573827</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2009 Mar;23(3):327-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19111923</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2007 Jan 13;369(9556):107-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17223473</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann N Y Acad Sci. 2001 Mar;933:185-200</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12000020</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2016 Nov 29;13(11):e1002188</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27898678</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Exp Pharmacol Physiol. 2017 Dec;44 Suppl 1:9-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28378496</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Adv. 2015 Feb;1(1):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26079000</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Neurobiol. 2017 Nov;54(9):6806-6819</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27766535</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychoneuroendocrinology. 2013 Sep;38(9):1835-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23639252</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Gerontol. 2014 Mar;51:15-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24365661</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2017 Jun 1;169(6):1000-1011</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28575665</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 2003 Jul 14;163(13):1530-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12860574</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9203-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10922071</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011 Mar 23;6(3):e17837</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21448457</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Aging Sci. 2015;8(2):158-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26212055</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurosci Biobehav Rev. 2015 Aug;55:333-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25999120</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Epidemiol. 2015 Oct;44(5):1688-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26385867</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Chromosomes Cancer. 2017 Sep;56(9):700-708</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28593741</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nurs Res. 2014 Jul-Aug;63(4):289-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24977726</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4519-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24616496</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ageing Res Rev. 2016 Jan;25:55-69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26616852</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Popul Health Metr. 2005 Jul 22;3:8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16042777</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Spine (Phila Pa 1976). 2000 Dec 15;25(24):3130-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11124729</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 2014 Sep;99(9):E1671-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24762112</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Transl Res. 2013 Dec;162(6):333-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24070997</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 2002 May 15;30(10):e47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12000852</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
</list>
<tree>
<country name="États-Unis">
<noRegion>
<name sortKey="Rajeevan, Mangalathu S" sort="Rajeevan, Mangalathu S" uniqKey="Rajeevan M" first="Mangalathu S" last="Rajeevan">Mangalathu S. Rajeevan</name>
</noRegion>
<name sortKey="Lin, Jin Mann S" sort="Lin, Jin Mann S" uniqKey="Lin J" first="Jin-Mann S" last="Lin">Jin-Mann S. Lin</name>
<name sortKey="Murray, Janna" sort="Murray, Janna" uniqKey="Murray J" first="Janna" last="Murray">Janna Murray</name>
<name sortKey="Oakley, Lisa" sort="Oakley, Lisa" uniqKey="Oakley L" first="Lisa" last="Oakley">Lisa Oakley</name>
<name sortKey="Unger, Elizabeth R" sort="Unger, Elizabeth R" uniqKey="Unger E" first="Elizabeth R" last="Unger">Elizabeth R. Unger</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000917 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000917 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:29486769
   |texte=   Association of chronic fatigue syndrome with premature telomere attrition.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:29486769" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a StressCovidV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021